Feb 06, 2024 / 10:00PM GMT
Operator
Good afternoon. Thank you for attending the Fourth Quarter and Full Year 2023 Gilead Sciences Earnings Conference Call. My name is Victoria, and I'll be your moderator today.
(Operator Instructions) I would now like to pass the conference over to your host, Jacquie Ross. Thank you. You may proceed, Jacquie.
Jacquie Ross - Gilead Sciences, Inc. - VP of IR
Thank you, operator, and good afternoon, everyone.
Just after market close today, we issued a press release with earnings results for the fourth quarter and full year of 2023. The press release, slides and supplementary data are available on the Investors section of our website at gilead.com.
The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial Officer; Johanna Mercier, our Chief Medical Officer, Merdad Parsey; and our Chief Financial Officer, Andrew Dickinson. After that, we'll open the call to Q&A where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.
Before we get started,
Q4 2023 Gilead Sciences Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers